摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-6-((phenylamino)methyl)-L-gluco-hex-2-enonic acid | 1428441-18-2

中文名称
——
中文别名
——
英文名称
5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-6-((phenylamino)methyl)-L-gluco-hex-2-enonic acid
英文别名
(2S,3R,4S)-3-acetamido-4-amino-2-(anilinomethyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-6-((phenylamino)methyl)-L-gluco-hex-2-enonic acid化学式
CAS
1428441-18-2
化学式
C15H19N3O4
mdl
——
分子量
305.334
InChiKey
PYBCZACBPIQGQG-FPMFFAJLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    114
  • 氢给体数:
    4
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    methyl 5-acetamido-2,6-anhydro-4-azido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acidsodium periodate氢气 、 sodium cyanoborohydride 、 溶剂黄146 、 lithium hydroxide 作用下, 以 甲醇 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 1.5h, 生成 5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-6-((phenylamino)methyl)-L-gluco-hex-2-enonic acid
    参考文献:
    名称:
    Identification of Selective Inhibitors for Human Neuraminidase Isoenzymes Using C4,C7-Modified 2-Deoxy-2,3-didehydro-N-acetylneuraminic Acid (DANA) Analogues
    摘要:
    In the past two decades, human neuraminidases (human sialidases, hNEUs) have been found to be involved in numerous pathways in biology. The development of selective and potent inhibitors of these enzymes will provide critical tools for glycobiology, help to avoid undesired side effects of antivirals, and may reveal new small-molecule therapeutic targets for human cancers. However, because of the high active site homology of the hNEU isoenzymes, little progress in the design and synthesis of selective inhibitors has been realized. Guided by our previous studies of human NEU3 inhibitors, we designed a series of C4,C7-modified analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) and tested them against the full panel of hNEU isoenzymes (NEU1, NEU2, NEU3, NEU4). We identified inhibitors with up to 38-fold selectivity for NEU3 and 12-fold selectivity for NEU2 over all other isoenzymes. We also identified compounds that targeted NEU2 and NEU3 with similar potency.
    DOI:
    10.1021/jm301892f
点击查看最新优质反应信息

文献信息

  • Identification of Selective Inhibitors for Human Neuraminidase Isoenzymes Using C4,C7-Modified 2-Deoxy-2,3-didehydro-<i>N</i>-acetylneuraminic Acid (DANA) Analogues
    作者:Yi Zhang、Amgad Albohy、Yao Zou、Victoria Smutova、Alexey V. Pshezhetsky、Christopher W. Cairo
    DOI:10.1021/jm301892f
    日期:2013.4.11
    In the past two decades, human neuraminidases (human sialidases, hNEUs) have been found to be involved in numerous pathways in biology. The development of selective and potent inhibitors of these enzymes will provide critical tools for glycobiology, help to avoid undesired side effects of antivirals, and may reveal new small-molecule therapeutic targets for human cancers. However, because of the high active site homology of the hNEU isoenzymes, little progress in the design and synthesis of selective inhibitors has been realized. Guided by our previous studies of human NEU3 inhibitors, we designed a series of C4,C7-modified analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) and tested them against the full panel of hNEU isoenzymes (NEU1, NEU2, NEU3, NEU4). We identified inhibitors with up to 38-fold selectivity for NEU3 and 12-fold selectivity for NEU2 over all other isoenzymes. We also identified compounds that targeted NEU2 and NEU3 with similar potency.
查看更多